Keyword: Congress

The top 3 House Democrat leaders have collected over $2.3 million total in campaign contributions from drugmakers.

AARP is taking on Big Pharma with a new campaign to convince lawmakers to resist drug industry lobbying.

Zeroing in on the spread between drug prices in the U.S. and elsewhere, two lawmakers have released the latest proposal to try to keep a lid on prices.

Tuesday's midterm results already brought a dose of new promises to tackle drug prices. But that’s not the only headache pharma faces in the House.

If Republicans can keep the Senate on Tuesday, the pharma industry will likely dodge meaningful pricing reform, according to two experts.

Pharma has come under political pressure in Washington, D.C., and lobby spending figures indicate the industry is taking the threat seriously.

Under a bipartisan opioid bill finalized by Congress, drugmakers will have to disclose payments made to nurses and physician assistants as well.

The drug industry has been seeking relief from a Medicare Part D change that'll cost the industry billions, but it came up short in a recent attempt.

After HHS proposed a rule that would shake up or eliminate drug rebates, a watchdog wants to know if agency chief Alex Azar has ulterior motives.

What do polarized senators dislike more than their partisan opponents? Pharma advertising, apparently.